ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer.

Molecular Cancer Therapeutics
James GreenawayJim Petrik

Abstract

Epithelial ovarian cancer (EOC) is the fifth most common cancer in women and is characterized by a low 5-year survival rate. One strategy that can potentially improve the overall survival rate in ovarian cancer is the use of antitumor agents such as ABT-510. ABT-510 is a small mimetic peptide of the naturally occurring antiangiogenic compound thrombospondin-1 and has been shown to significantly reduce tumor growth and burden in preclinical mouse models and in naturally occurring tumors in dogs. This is the first evaluation of ABT-510 in a preclinical model of human EOC. Tumorigenic mouse surface epithelial cells were injected into the bursa of C57BL/6 mice that were treated with either 100 mg/kg ABT-510 or an equivalent amount of PBS. ABT-510 caused a significant reduction in tumor size, ascites fluid volume, and secondary lesion dissemination when compared with PBS controls. Analysis of the vasculature of ABT-510-treated mice revealed vascular remodeling with smaller diameter vessels and lower overall area, increased number of mature vessels, and decreased tissue hypoxia. Tumors of ABT-510-treated mice had a significantly higher proportion of apoptotic tumor cells compared with the PBS-treated controls. Immunoblot analysis of ...Continue Reading

References

Dec 1, 1990·British Journal of Cancer·J M ClineJ A Raleigh
Nov 18, 1971·The New England Journal of Medicine·J Folkman
Dec 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J RakR S Kerbel
Aug 11, 1997·The Journal of Cell Biology·D W DawsonN P Bouck
Oct 10, 1997·American Journal of Obstetrics and Gynecology·O AbulafiaD M Sherer
Jun 24, 1999·Annals of Surgical Oncology·B K ZebrowskiL M Ellis
Mar 31, 2000·Experimental Cell Research·T G CrossJ M Lord
Dec 18, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Isao InokiYasunori Okada
Jan 10, 2002·The Journal of Biological Chemistry·Elisa LorenzoJuan Miguel Redondo
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Frank K ReiherSteven C Campbell
May 11, 2002·Journal of Cellular and Molecular Medicine·Jack Lawler
Oct 3, 2002·Nature Reviews. Cancer·Robert Kerbel, Judah Folkman
Nov 29, 2002·Molecular Pathology : MP·E S Bamberger, C W Perrett
Apr 26, 2003·Matrix Biology : Journal of the International Society for Matrix Biology·Lucas C Armstrong, Paul Bornstein
May 10, 2003·Obstetrics and Gynecology·Solveig TingulstadBjørn Hagen
May 22, 2003·The American Journal of Pathology·Harold F Dvorak
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Karen H LuRobert C Bast
Jun 2, 2004·Nature Reviews. Cancer·Robert S Kerbel, Barton A Kamen
Jun 15, 2004·Journal of the American College of Surgeons·Rony A Adam, Yehuda G Adam
Jul 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald HoekstraElisabeth G E de Vries
Jan 13, 2006·Biochimica Et Biophysica Acta·Bin RenRoya Khosravi-Far
Oct 25, 2006·Experimental Biology and Medicine·Limin HuRobert B Jaffe
Nov 4, 2006·The Lancet Oncology·David S P TanStanley B Kaye
Dec 13, 2006·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A P M HeintzU Beller
Dec 26, 2006·Journal of Hepatology·Rita CariniEmanuele Albano
Dec 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anthony RuskChand Khanna
Jan 24, 2007·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 10, 2007·The Journal of Biological Chemistry·Jeff S IsenbergDavid D Roberts
May 9, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Iclal OcakPeter Choyke
May 31, 2007·International Journal of Cancer. Journal International Du Cancer·Denis LaneAlain Piché
Jun 7, 2007·American Journal of Clinical Oncology·Svetomir N MarkovicEdward T Creagan
Jun 15, 2007·Microvascular Research·Dai Fukumura, Rakesh K Jain
Jun 23, 2007·BMJ : British Medical Journal·Janice Hopkins Tanne
Nov 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scot EbbinghausRobert Figlin

❮ Previous
Next ❯

Citations

May 9, 2012·Expert Reviews in Molecular Medicine·Debabrata Patra, Linda J Sandell
Aug 24, 2011·Carcinogenesis·Kate LawrensonSimon A Gayther
May 4, 2012·Cold Spring Harbor Perspectives in Medicine·Patrick R Lawler, Jack Lawler
Jul 19, 2011·Mediators of Inflammation·Zenaida Lopez-DeeLinda S Gutierrez
Jul 31, 2010·Journal of Oncology·N E CampbellJ Petrik
Nov 3, 2010·Proceedings of the National Academy of Sciences of the United States of America·Feng SuRobin Farias-Eisner
May 20, 2014·Cancer Letters·Dongdong WuYanzhang Li
Oct 3, 2009·Journal of Cell Communication and Signaling·Paul Bornstein
Mar 19, 2014·Reproductive Biology and Endocrinology : RB&E·Kata OszJim Petrik
Dec 6, 2011·Expert Opinion on Therapeutic Targets·Jack Henkin, Olga V Volpert
Feb 26, 2013·Journal of Reproductive Immunology·Andrew K EdwardsChandrakant Tayade
Jul 17, 2012·Taiwanese Journal of Obstetrics & Gynecology·Wen-Hsiang SuPeng-Hui Wang
Jun 26, 2012·International Journal of Cancer. Journal International Du Cancer·Toshiaki TsujiHiroki Yamaue
Sep 10, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Jennifer N Sims, Jack Lawler
Jul 23, 2015·Journal of Peptide Science : an Official Publication of the European Peptide Society·Emiko MatsumotoKazuhiro Chiba
May 15, 2013·International Journal of Cardiology·Smriti Murali Krishna, Jonathan Golledge
Jun 29, 2017·Cancer Biomarkers : Section a of Disease Markers·Aneta Cymbaluk-PłoskaJanusz Menkiszak
Nov 22, 2017·Oncotarget·Romain BibesFabrice Lalloué
Nov 15, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Samantha RussellJim Petrik
Jun 6, 2015·Oncotarget·Albin JeanneStéphane Dedieu
Sep 13, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kathy MatuszewskaJim Petrik
Oct 9, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chelsea BolyardBalveen Kaur
Aug 17, 2011·Molecular Cancer Therapeutics·Nicole CampbellJim Petrik
Feb 26, 2021·Neuro-oncology Advances·Tiffany S Y ChanAnnie Huang
Oct 21, 2010·Journal of Ovarian Research·Bridget A QuinnDenise C Connolly

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis